Results 131 to 140 of about 17,080,653 (424)

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing

open access: yesThe Prostate, 2018
Genetic testing capability and guidelines are rapidly expanding to assess inherited prostate cancer (PCA). Clinical genetic data from multigene testing can provide insights into the germline pathogenic variant (PV) spectrum and correlates in men with PCA
V. Giri   +7 more
semanticscholar   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

Continuous salt stress-induced long non-coding RNAs and DNA methylation patterns in soybean roots

open access: yesBMC Genomics, 2019
Background Environmental stimuli can activate a series of physiological and biochemical responses in plants accompanied by extensive transcriptional reprogramming.
Rui Chen   +7 more
doaj   +1 more source

Attitudes Toward Breast Cancer Genetic Testing in Five Special Population Groups

open access: yes, 2015
Purpose: This study examined interest in and attitudes toward genetic testing in 5 different population groups. Methods: The survey included African American, Asian American, Latina, Native American, and Appalachian women with varying familial histories ...
Burhansstipanov, Linda   +9 more
core  

Ethical qualms about genetic prognosis [PDF]

open access: yes, 2016
The debate about direct-to-consumer genetic testing has centred on whether consumers are the best judges of their own clinical care. Inthis article, I also examine whether the science of personalized medicine is really as advanced as its proponents
Dickenson, Donna
core   +1 more source

Demographic differences in the utilization of clinical and direct-to-consumer genetic testing.

open access: yesJournal of Genetic Counseling, 2019
Genetic testing has increased over the last decade due to growth in the number of clinical and direct-to-consumer (DTC) tests. However, there is uncertainty about how increased DTC genetic testing affects disparities.
Nikki M. Carroll   +10 more
semanticscholar   +1 more source

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report

open access: yesFrontiers in Genetics
Sex discordance between cell-free DNA (cfDNA) testing and ultrasound examination is rare but can cause significant patient discomfort and uncertainty.
Nuria Balaguer   +6 more
doaj   +1 more source

Searching for invariants using genetic programming and mutation testing [PDF]

open access: yes, 2011
Invariants are concise and useful descriptions of a program's behaviour. As most programs are not annotated with invariants, previous research has attempted to automatically generate them from source code.
Clark, J.A., Ratcliff, S., White, D.R.
core   +1 more source

On the valuation of genetic tests [PDF]

open access: yesPersonalized Medicine, 2004
10.1517/17410541.1.1.125 © 2 Continuing progress in the field of human genetics may lead to more widespread use of genetic screening in medicine. While hundreds of publications have so far reported the identification of novel genetic disease risk factors and genetic mediators of treatment response, only a few FDA-approved genetic tests are presently ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy